ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MannKind and United Therapeutics NDA for Tyvaso DPI™ Accepted by U.S. FDA
June 18, 2021MannKind Corporation and United Therapeutics Corporation announced that the U.S. FDA accepted for priority review the New Drug Application (NDA) for Tyvaso DPI™ (inhaled treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and ...
Pharma Sources Insight January 2025
